Hepatologia

Lessons learned from viral hepatitis testing that inform law and policy responses to steatotic liver disease.

Nature reviews. Gastroenterology & hepatology. 2026 Apr; 23(Apr):355-367. doi: 10.1038/s41575-026-01174-z. pii: .

An Update on Bile Acid-Regulated Signalling in the Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease.

Liver international : official journal of the International Association for the Study of the Liver. 2026 Apr; 46(Apr):e70586. doi: 10.1111/liv.70586. pii: .

Defining Noninvasive Criteria for Indicating Drug Therapy in Metabolic Dysfunction-associated Steatotic Liver Disease in Clinical Practice.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2026 Apr; 24(Apr):1044-1054. doi: 10.1016/j.cgh.2025.08.023. pii: S1542-3565(25)00743-8.

AASLD AST Practice Guideline on adult liver transplantation: Diagnosis and management of graft-related complications.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2026 Mar; 32(Mar):444-490. doi: 10.1097/LVT.0000000000000715. pii: .

An Expert Consensus Delphi Panel in Metabolic Dysfunction- and Alcohol-associated Liver Disease: Opportunities and Challenges in Clinical Practice.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2026 Mar; 24(Mar):633-645.e4. doi: 10.1016/j.cgh.2025.02.017. pii: S1542-3565(25)00325-8.

Hepatitis B: A Review.

JAMA. 2026 Jun; 335(Jun):1879-1892. doi: 10.1001/jama.2026.6070. pii: .

Predicting decompensation in unresectable hepatocellular carcinoma on atezolizumab plus bevacizumab: the ARTE Score.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2026 May; doi: 10.1016/j.cgh.2026.04.033. pii: S1542-3565(26)00389-7.

Pharmacotherapy for metabolic dysfunction-associated steatohepatitis: heart-liver co-management.

The lancet. Gastroenterology & hepatology. 2026 Jun; 11(Jun):521-537. doi: 10.1016/S2468-1253(25)00323-1. pii: S2468-1253(25)00323-1.

Individualising endpoints in chronic HBV treatment: HBsAg loss and beyond.

Journal of hepatology. 2026 Apr; 84(Apr):823-828. doi: 10.1016/j.jhep.2025.12.006. pii: S0168-8278(25)02724-2.

Intratumour ploidy heterogeneity and clonal evolution in hepatocellular carcinoma.

Journal of hepatology. 2026 Apr; 84(Apr):776-792. doi: 10.1016/j.jhep.2025.11.015. pii: S0168-8278(25)02654-6.

Consensus position statements for the standardized application of histological grading and staging systems in MASH clinical trials.

Journal of hepatology. 2026 Apr; 84(Apr):693-701. doi: 10.1016/j.jhep.2025.09.019. pii: S0168-8278(25)02501-2.

Preventing First and Further Decompensation in Advanced Chronic Liver Disease.

Liver international : official journal of the International Association for the Study of the Liver. 2026 Apr; 46(Apr):e70568. doi: 10.1111/liv.70568. pii: .

Metabolic liver imaging: What you need to know.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2026 Apr; 58(Apr):433-443. doi: 10.1016/j.dld.2026.02.010. pii: S1590-8658(26)00288-4.

Inpatient Management of Patients With Cirrhosis.

Annals of internal medicine. 2026 Apr; 179(Apr):ITC49-ITC64. doi: 10.7326/ANNALS-26-00513. pii: .

Chronic liver disease and hepatology care in transgender and gender diverse populations.

The lancet. Gastroenterology & hepatology. 2026 Apr; 11(Apr):334-344. doi: 10.1016/S2468-1253(25)00287-0. pii: S2468-1253(25)00287-0.

Early liver transplantation in alcohol-associated liver disease-Evolution of practice, patient selection, management, and outcomes.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2026 Mar; 32(Mar):428-443. doi: 10.1097/LVT.0000000000000732. pii: .

BCLC strategy for prognosis prediction and treatment recommendations: The 2026 update.

Journal of hepatology. 2026 Mar; 84(Mar):631-654. doi: 10.1016/j.jhep.2025.10.020. pii: S0168-8278(25)02571-1.

Hepatocellular carcinoma arising from ectopic liver tissue: a systematic review of the literature.

European journal of gastroenterology & hepatology. 2026 Mar; 38(Mar):243-258. doi: 10.1097/MEG.0000000000003069. pii: .

AISF-SIMIT practice guidance on treatment of hepatitis d virus (HDV): A 2025 update.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2026 Mar; 58(Mar):297-307. doi: 10.1016/j.dld.2025.12.017. pii: S1590-8658(25)01257-5.

Biomarkers in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Gastroenterology clinics of North America. 2026 Mar; 55(Mar):185-202. doi: 10.1016/j.gtc.2025.09.003. pii: S0889-8553(25)00066-4.

Biomarkers for the Diagnosis of Cirrhosis and Cirrhosis-Related Complications.

Gastroenterology clinics of North America. 2026 Mar; 55(Mar):203-216. doi: 10.1016/j.gtc.2025.10.006. pii: S0889-8553(25)00083-4.

International liver transplantation society practice guideline update on portopulmonary hypertension.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2025 Mar; doi: 10.1097/LVT.0000000000000600. pii: .

British Society of Gastroenterology guidelines for diagnosis and management of autoimmune hepatitis.

Gut. 2025 Aug; 74(Aug):1364-1409. doi: 10.1136/gutjnl-2024-333171. pii: e333171.

EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma.

Journal of hepatology. 2025 Feb; 82(Feb):315-374. doi: 10.1016/j.jhep.2024.08.028. pii: S0168-8278(24)02508-X.

The 2024 ILTS-ILCA consensus recommendations for liver transplantation for HCC and intrahepatic cholangiocarcinoma.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2025 Jun; 31(Jun):815-831. doi: 10.1097/LVT.0000000000000589. pii: .

AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.

Hepatology (Baltimore, Md.). 2023 Dec; 78(Dec):1922-1965. doi: 10.1097/HEP.0000000000000466. pii: .

A multi-society Delphi consensus statement on new fatty liver disease nomenclature.

Journal of hepatology. 2023 Jun; doi: 10.1016/j.jhep.2023.06.003. pii: S0168-8278(23)00418-X.

EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma.

Journal of hepatology. 2023 Jul; 79(Jul):181-208. doi: 10.1016/j.jhep.2023.03.010. pii: S0168-8278(23)00185-X.

EASL Clinical Practice Guidelines on hepatitis delta virus.

Journal of hepatology. 2023 Aug; 79(Aug):433-460. doi: 10.1016/j.jhep.2023.05.001. pii: S0168-8278(23)00317-3.

EASL Clinical Practice Guidelines on acute-on-chronic liver failure.

Journal of hepatology. 2023 Aug; 79(Aug):461-491. doi: 10.1016/j.jhep.2023.04.021. pii: S0168-8278(23)00244-1.

Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference.

Journal of hepatology. 2023 Nov; 79(Nov):1254-1269. doi: 10.1016/j.jhep.2023.06.002. pii: S0168-8278(23)00417-8.

ACG Clinical Guideline: Focal Liver Lesions.

The American journal of gastroenterology. 2024 Jul; 119(Jul):1235-1271. doi: 10.14309/ajg.0000000000002857. pii: .

Consensus Guidelines: Best Practices for the Prevention, Detection and Management of Hepatitis B Virus Reactivation in Clinical Trials with Immunosuppressive/Immunomodulatory Therapy.

Drug safety. 2024 Apr; 47(Apr):321-332. doi: 10.1007/s40264-024-01399-4. pii: .

AGA Clinical Practice Update on the Use of Vasoactive Drugs and Intravenous Albumin in Cirrhosis: Expert Review.

Gastroenterology. 2024 Jan; 166(Jan):202-210. doi: 10.1053/j.gastro.2023.10.016. pii: S0016-5085(23)05143-0.

AGA Clinical Practice Update on the Role of Noninvasive Biomarkers in the Evaluation and Management of Nonalcoholic Fatty Liver Disease: Expert Review.

Gastroenterology. 2023 Oct; 165(Oct):1080-1088. doi: 10.1053/j.gastro.2023.06.013. pii: S0016-5085(23)00881-8.

Hepatitis B: A Review.

JAMA. 2026 Jun; 335(Jun):1879-1892. doi: 10.1001/jama.2026.6070. pii: .

Pharmacotherapy for metabolic dysfunction-associated steatohepatitis: heart-liver co-management.

The lancet. Gastroenterology & hepatology. 2026 Jun; 11(Jun):521-537. doi: 10.1016/S2468-1253(25)00323-1. pii: S2468-1253(25)00323-1.

Predicting decompensation in unresectable hepatocellular carcinoma on atezolizumab plus bevacizumab: the ARTE Score.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2026 May; doi: 10.1016/j.cgh.2026.04.033. pii: S1542-3565(26)00389-7.

Individualising endpoints in chronic HBV treatment: HBsAg loss and beyond.

Journal of hepatology. 2026 Apr; 84(Apr):823-828. doi: 10.1016/j.jhep.2025.12.006. pii: S0168-8278(25)02724-2.

Metabolic liver imaging: What you need to know.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2026 Apr; 58(Apr):433-443. doi: 10.1016/j.dld.2026.02.010. pii: S1590-8658(26)00288-4.

Consensus position statements for the standardized application of histological grading and staging systems in MASH clinical trials.

Journal of hepatology. 2026 Apr; 84(Apr):693-701. doi: 10.1016/j.jhep.2025.09.019. pii: S0168-8278(25)02501-2.

Defining Noninvasive Criteria for Indicating Drug Therapy in Metabolic Dysfunction-associated Steatotic Liver Disease in Clinical Practice.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2026 Apr; 24(Apr):1044-1054. doi: 10.1016/j.cgh.2025.08.023. pii: S1542-3565(25)00743-8.

Inpatient Management of Patients With Cirrhosis.

Annals of internal medicine. 2026 Apr; 179(Apr):ITC49-ITC64. doi: 10.7326/ANNALS-26-00513. pii: .

Chronic liver disease and hepatology care in transgender and gender diverse populations.

The lancet. Gastroenterology & hepatology. 2026 Apr; 11(Apr):334-344. doi: 10.1016/S2468-1253(25)00287-0. pii: S2468-1253(25)00287-0.

Intratumour ploidy heterogeneity and clonal evolution in hepatocellular carcinoma.

Journal of hepatology. 2026 Apr; 84(Apr):776-792. doi: 10.1016/j.jhep.2025.11.015. pii: S0168-8278(25)02654-6.